ProLung Company Profile

09:42 EDT 20th March 2018 | BioPortfolio

News Articles [4 Associated News Articles listed on BioPortfolio]

IPO could bring in $7M for ProLung

An initial public offering of 0.93 million shares was priced by Salt Lake City-based ProLung in hopes of raising $7 million.  -More- 

ProLung proposes $8.6M IPO

Epigenomics AG gets CE-IVD Mark for Lung Cancer Test Epi proLung(R)

DGAP-News: Epigenomics AG / Key word(s): Product Launch 19.12.2017 / 08:45 The issuer is solely responsible for the content of this announcement. Press release Epigenomics AG gets CE-IVD M...

EU OKs Epigenomics' blood-based lung cancer test

European regulators gave Epigenomics CE-IVD marking for its Epi proLung, a blood-based test that detects lung cancer by spott -More- 

Drugs and Medications [0 Results]


PubMed Articles [0 Results]


Clinical Trials [1 Associated Clinical Trials listed on BioPortfolio]

Clinical Trial of Chinese Herbal Medicine for Idiopathic Pulmonary Fibrosis (IPF)

This open label clinical study will be conducted in School of Chinese Medicine Clinics at The University of Hong Kong (HKU) to preliminarily determine whether treatment with the herbal for...

More Information about "ProLung" on BioPortfolio

We have published hundreds of ProLung news stories on BioPortfolio along with dozens of ProLung Clinical Trials and PubMed Articles about ProLung for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of ProLung Companies in our database. You can also find out about relevant ProLung Drugs and Medications on this site too.

Quick Search


Corporate Database Quicklinks

Searches Linking to this Company Record